Evidence map›Paper›PMID 21990355›Full record

ArticleThe Journal of biological chemistry2011

α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter.

Jarod Swant, J Shawn Goodwin, Ashley North, Ahmad Abdul Ali, Joyonna Gamble-George, Sanika Chirwa, Habibeh Khoshbouei

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Neurons and Glia Interplay in α-Synucleinopathies.International journal of molecular sciences · 2021
    Review
  17. Review
  18. The Membrane Interaction of Alpha-Synuclein.Frontiers in cellular neuroscience · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jarod SwantDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208.
J Shawn GoodwinDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208.
Ashley NorthDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208.
Ahmad Abdul AliJames Madison University, Harrisonburg, Virginia 22807.
Joyonna Gamble-GeorgeDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208.
Sanika ChirwaDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208.
Habibeh KhoshboueiDepartment of Biomedical Sciences, Meharry Medical College, Nashville, Tennessee 37208. Electronic address: hkhoshbouei@mmc.edu.
Meharry Medical College · USJames Madison University · US

Funding

Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
Translational Pathology CoreU54CA163069 · NCI · MEHARRY MEDICAL COLLEGE · PI BALLARD, BILLY RAY · 2011 to 2025
$18.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · PI GOODWIN, JEFFREY SHAWN · 2009 to 2011
$12.9M
Alpha-synuclein Regulates Dopamine Transporter FunctionsR01NS071122 · NINDS · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2022
$3.9M
Methamphetamine regulates the dopamine transporter via an intracellular mechanismR01DA026947 · NIDA · UNIVERSITY OF FLORIDA · PI KHOSHBOUEI, HABIBEH · 2010 to 2019
$3.5M
SNRP Project at Meharry Medical CollegeU01NS041071 · NINDS · MEHARRY MEDICAL COLLEGE · PI CHARLTON, CLIVEL G. · 2009 to 2010
$2.2M
Methamphetamine Research Program at Meharry Medical CollegeR24DA021471 · NIDA · MEHARRY MEDICAL COLLEGE · PI RUCKER, HUBERT K. · 2008 to 2012
$2.0M
Live Cell Imaging Confocal Microscope SystemS10RR025497 · NCRR · MEHARRY MEDICAL COLLEGE · PI GOODWIN, JEFFREY SHAWN · 2010 to 2010
$419k
NCI NIH HHS U54 CA163069NCRR NIH HHS S10 RR025497NCRR NIH HHS S10RR0254970NCRR NIH HHS U54 RR026140NCRR NIH HHS U54RR026140NIDA NIH HHS DA021471NIDA NIH HHS DA026947NIDA NIH HHS R01 DA026947NIDA NIH HHS R24 DA021471NIMHD NIH HHS U54 MD007593NINDS NIH HHS NS071122NINDS NIH HHS R01 NS071122NINDS NIH HHS U01 NS041071NINDS NIH HHS U01NS041071
6 · The paper itself

Abstract

Dysregulation of dopamine (DA) homeostasis is implicated in neurodegenerative diseases, drug addiction, and neuropsychiatric disorders. The neuronal plasma membrane dopamine transporter (DAT) is essential for the maintenance of DA homeostasis in the brain. α-Synuclein is a 140-amino acid protein that forms a stable complex with DAT and is linked to the pathogenesis of neurodegenerative disease. To elucidate the potential functional consequences of DAT/α-synuclein interaction, we explored α-synuclein modulation of DAT activity in midbrain dopaminergic neurons obtained from TH::RFP mice, immortalized DA neurons, and a heterologous system expressing DAT. We used dual pipette whole cell patch clamp recording to measure the DAT-mediated current before and after dialysis of recombinant α-synuclein into immortalized DA neurons. Our data suggest that intracellular α-synuclein induces a Na+ independent but Cl--sensitive inward current in DAT-expressing cells. This current is blocked by DAT blocker GBR12935 and is absent when heat-inactivated α-synuclein is dialyzed into these cells. The functional consequence of this interaction on DAT activity was further examined with real-time monitoring of transport function using a fluorescent substrate of DAT, 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP+). Overexpression of α-synuclein in DAT-positive immortalized DA neurons and CHO cells expressing DAT decreased the magnitude and rate of DAT-mediated substrate uptake without a decrease in the initial binding of the substrate at the plasma membrane. Taken together our findings are consistent with the interpretation that DAT/α-synuclein interaction at the cell surface results in a DAT-dependent, Na+-insensitive, Cl-sensitive inward current with a decrease in substrate uptake, suggesting that DAT/α-synuclein interaction can modulate dopamine transmission and thus neuronal function.

Indexed as

alpha-SynucleinAnimalsBrainChloridesCHO CellsCricetinaeCricetulusDopamineDopamine Plasma Membrane Transport ProteinsFluorescent DyesHumansMiceNeurodegenerative DiseasesNeuronsPatch-Clamp Techniquesalpha-SynucleinChloridesDopamineDopamine Plasma Membrane Transport ProteinsFluorescent Dyes

Identifiers

PMID21990355
PMCPMC3243541
OpenAlexW2074495436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.